Skip to main content
A phase 1B multiple ascending dose study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of a medium chain triglyceride supplement in Alzheimer’s disease
Published Web Location
https://alz-journals.onlinelibrary.wiley.com/doi/abs/10.1002/alz.037960No data is associated with this publication.